Le Lézard
Classified in: Health
Subject: PER

Aquavit Pharmaceuticals, Inc. Names Timothy Sherwood Chief Operating Officer


NEW YORK, May 17, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.

Prior to the promotion, Sherwood headed up Aquavit's Global Commercial Operations. Effective immediately, Sherwood will assume responsibility for overall administration, commercial operations, business development and strategy.  Sherwood will also be responsible for the alignment and prioritization of Aquavit's investments and ensuring operational excellence across the company.

"Tim is a seasoned and trusted leader who consistently delivers results.  He is uniquely qualified to drive strategic prioritization and accountability within Aquavit, with a laser-focus on operational excellence," said Sobin Chang, President and CEO, Aquavit. "We are so thrilled to promote great talent from within our organization."

Sherwood joined Aquavit in early 2019 as Vice President of Finance and Human Resources and quickly moved into the role of Senior Vice President, Global Commercial Operations. He has over 18 years of experience in finance, accounting, operations, strategic planning, and human resources across various industries. Prior to joining Aquavit, he was Vice President of Finance at an internationally recognized consulting firm.

"Aquavit's strategy has never been more compelling, and we have won the hearts and minds of our customers," said Sherwood. "I am incredibly energized to help lead the company to its next phase of innovation tied with operational excellence."

About Aquavit Pharmaceuticals, Inc.
Aquavit Pharmaceuticals, Inc. is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies. Aquavit Pharmaceuticals, Inc. focuses on personalized medicine to improve patients' health, maximize the efficiency of our medical community, and support the pharmacoeconomics of payers.

SOURCE Aquavit Pharmaceuticals, Inc.


These press releases may also interest you

at 23:15
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

at 18:50
NCPDP Foundation Funds New Project to Streamline REMS Process for the Industry
Getting specialty medications into...

at 18:30
Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Riding the Trend: Baros Maldives' Immersive Water Therapy
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
NCPDP's National Facilitator Model Pilot Project Enters Second Phase
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

More news about Health...


News published on and distributed by: